window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 13, 2026

  • News
  • About Us
Contact Us

Events and Conferences

  • CDMOs & Manufacturing,Drug Development,Events and Conferences,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CPhI & PMEC India 2025 showcases pharma innovation and sets stage for expanded 2026 edition

    The 18th edition of CPhI & PMEC India, South Asia’s [...]

    January 12, 2026
  • Drug Delivery & Formulation,Events and Conferences,Manufacturing,Packaging,Sustainability

    Pharmapack 2026 to return to Paris with focus on GLP-1 therapies and sustainable packaging

    Pharmapack will return to Paris in January 2026, with this [...]

    January 8, 2026
  • Artificial Intelligence,Clinical Development,Data Management,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Pistoia Alliance warns of scientific content crisis limiting accuracy of AI in life sciences R&D

    The Pistoia Alliance has reported new findings pointing to a [...]

    December 3, 2025
  • Cell & Gene Therapy,Clinical studies,Clinical Trials,Events and Conferences,Hematology,Oncology,Pharmaceuticals and therapeutics

    CytoAgents to present new CTO1681 clinical safety data at ASH annual meeting

    CytoAgents will present new clinical safety data for CTO1681 at [...]

    December 3, 2025
  • Chronic diseases,Events and Conferences,Global health,Obesity,Women's Health

    UAE obesity conference highlights global advances shaping the future of obesity care

    The 7th UAE Obesity Conference brought together international experts in [...]

    November 19, 2025
  • Events and Conferences,Facilities and infrastructure,Pharmaceuticals and therapeutics,Supply Chain & Logistics

    CPHI & PMEC India 2025 returns to Delhi as South Asia’s largest pharma event

    CPHI & PMEC India will return to the India Expo [...]

    November 17, 2025
  • Dermatology,Events and Conferences,Immunology,Mental health,Patient Centricity,Pharmaceuticals and therapeutics

    Almirall ImmunoSkin brings experts together to advance treatment of inflammatory skin diseases

    Almirall has hosted the fourth edition of ImmunoSkin, its annual [...]

    November 12, 2025
  • Biologics & Biosimilars,Biotech,Drug Development,Events and Conferences,Research & Development,Technology and platforms

    Abselion launches His-tag protein quantification kit and sensors for Amperia at PEGS Europe 2025

    Abselion has expanded its Amperia assay portfolio with the launch [...]

    November 11, 2025
  • Biotech,Clinical Development,Drug Development,Events and Conferences,Neurosciences,Pharmaceuticals and therapeutics,Research & Development

    Medicinova wins contract research and development innovation award at biotech breakthrough awards 2025

    MediciNova has been recognised with the Contract Research and Development [...]

    November 10, 2025
  • Biologics & Biosimilars,Biomanufacturing,Biotech,CDMOs & Manufacturing,Clinical Development,Events and Conferences,Partnerships & Funding,Pharmaceuticals and therapeutics

    Personal connections at CPhI Frankfurt 2025: How trust drives long-term pharma relationships

    A roundtable at CPhI Frankfurt 2025 with industry leaders from [...]

    November 5, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • CERo reports early safety signals and platelet transfusion-free interval in Phase 1 AML trial
    Categories: Cell & Gene Therapy, Clinical Development, Clinical Trials, Oncology, Research & Development
  • Breast cancer tops list of most-studied diseases for fifth consecutive year, Phesi analysis finds
    Categories: Artificial Intelligence, Clinical Development, Clinical Trials, Data Management, Oncology, Research & Development
  • TECregen raises CHF 10m (EUR 10.7m) seed financing and appoints Dr Bo Rode Hansen as chairman
    Categories: Biologics & Biosimilars, Biotech, Immunology, Partnerships & Funding, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top